Combinatrix Corp. (CBMX1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
CEO:
Mark D. McDonough
Employees:
55
310 GODDARD, SUITE 150, IRVINE, CA 92618
949-753-0624

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

CombiMatrix Corp. engages in the provision of clinical diagnostic services. It offers cytogenomic testing for preimplantation genetic testing, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company was founded in October 1995 and is headquartered in Irvine, CA.

Data derived from most recent annual or quarterly report
Market Cap 316.487 Million Shares Outstanding50.638 Million Avg 30-day Volume 44.155 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.51
Price to Revenue1.417 Debt to Equity0.0351 EBITDA-1.803 Million
Price to Book Value4.1864 Operating Margin-13.136999999999999 Enterprise Value19.882 Million
Current Ratio3.219 EPS Growth0.772 Quick Ratio2.944
1 Yr BETA 3.5672 52-week High/Low 0.0 / Profit Margin-13.1947
Operating Cash Flow Growth68.8211 Altman Z-Score-11.5584 Free Cash Flow to Firm -1.742 Million
View SEC Filings from CBMX1 instead.

View recent insider trading info

Combinatrix Corp. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CBMX1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CBMX1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOFFMAN ROBERT

  • Director
 No longer subject to file 2017-11-14 0

JESSUP R JUDD

  • Director
 No longer subject to file 2017-11-14 0

JONES JEREMY M

  • Director
 No longer subject to file 2017-11-14 0

BURELL SCOTT R CFO, SECRETARY & TREASURER

  • Officer
 No longer subject to file 2017-11-14 0

MCDONOUGH MARK D PRESIDENT AND CEO

  • Officer
  • Director
 No longer subject to file 2017-11-14 0

WHITE LALE

  • Director
 No longer subject to file 2017-11-14 0

VAN DEN BOOM DIRK

  • Director
 0 2017-02-27 0

GOTTLIEB SCOTT

  • Director
 4,804 2016-05-09 0

HAMILTON EDWARD ARTHUR

1,728,457 2015-02-25 0

TYSON ROBERT WESLIE CHIEF MEDICAL OFFICER

  • Officer
 7,500 2014-08-27 0

DING RICHARD

  • Director
 17,495 2014-02-20 0

HOCKETT RICHARD JR CHIEF MEDICAL OFFICER

  • Officer
  • Director
 1,000 2013-06-12 0

FELSENTHAL MARTIN R

  • Director
  • 10% Owner
 0 2013-01-02 0

MCGOWAN MARK

  • Director
 0 2013-01-02 0

LIMBER JOSEPH M

  • Director
 0 2012-02-28 0

ABELES JOHN H

  • Director
 0 2012-01-03 0

KUMAR AMIT

  • Director
 0 2012-01-03 0

CURRIE F RIDGON

  • Director
 0 2012-01-03 0

HLM VENTURE PARTNERS III, L.P.

HLM VENTURE ASSOCIATES III, LLC

CAHILL EDWARD L

GRUA PETER J

RAY RUSSELL T

  • 10% Owner
 1,595,896 2011-04-07 0

FORCHE DANIEL R SVP SALES & MKTG OF SUBSIDIARY

  • Officer
 11,399 2011-04-07 0

ANDERSON BROOKE P CHIEF OPERATING OFFICER

  • Officer
 No longer subject to file 2010-06-30 0

AKIN THOMAS B

  • Director
 0 2010-01-04 0

FUJI H SHO VP ENGINEERING & PRODUCTION

  • Officer
 0 2009-05-11 0

MOHAMMED MANSOOR CEO, CMDX, INC.

  • Officer
 0 2009-05-11 0

VRBANAC MICHAEL D COUNSEL

  • Officer
 0 2009-05-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments